AzTrials
AzTrials

Pilonidal SinusNCT06021392

Comparative Study Between Wide Local Excision and Minimal Excision of Pilonidal Sinus

An observational study of Pilonidal Sinus, run by Abanoub emad fayez.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Comparative study between wide local excision and minimal excision of pilonidal sinus Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Pilonidal Sinus
What is being tested?
Z plasty and minimal excision of pilonidal sinus
Type of treatment
Surgery or procedure
How many people
2 participants
Where
No sites listed yet
Study dates
1 Dec 2023to 1 Oct 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy people of both genders with or without history of PNS procedures before

Who may be able to join

  • Patients complaining of primary PNS and Recurrent PNS following Minimal excision

Who cannot join

  • Recurrent PNS following wide local excision

About this study

Comparative study between wide local excision and minimal excision of pilonidal sinus

Read the detailed description

Pilonidal sinus (PNS) disease is distributed in young adults who are supposed to be healthy with maximum productivity. Wide local excision creates a tissue gap, while the concept of minimal excision preserves healthy tissues with minimal tissue gap.

Pilonidal disease is a frequent suppurative condition that occurs twice as often in men as in women, usually between the ages of 15 and 30. Pilonidal disease is located beneath the skin of the sacro-coccygeal region. It presents acutely as an abscess under tension while the chronic form gives rise to intermittent discharge from pilonidal sinus(es). Diagnosis is clinical and usually straightforward. In the large majority of cases, treatment is surgical but there is no consensus as to the 'ideal' technique. Acute abscess must be evacuated and an off-midline incision seems preferable. Excision is the standard definitive treatment but the choice of wide versus limited excision on the school of thought. Minimal excision or debridement of the sinus and/or cavity through a midline or a separate paramedian excision can also be performed, leaving the wounds open or closed. These methods are simple and cost-efficient, and associated with low pain, rapid healing, and a rapid return to normal activity. A disadvantage is the higher recurrence rate; however, these methods can be used repeatedly for recurrences. Although recurrence rates seem high at first glance, the procedures can be successfully repeated for recurrences, achieving healing rates of over 90% for 1-2 interventions. Future well-designed trials are necessary to aid patient selection.

Conditions
Pilonidal Sinus
Being tested
Z plasty and minimal excision of pilonidal sinus
Medical subject headings
Pilonidal Sinus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Z plasty and minimal excision of pilonidal sinusProcedure or surgery

    The investigators will perform a " Z plasty " procedure and Minimal excision procedure for patients complaining of pilonidal sinus and the investigators will compare the outcomes and rate of recurrence of these two procedures

Study groups in NCT06021392
Study groupRoleWhat they receive
Wide local excision of pilonidal sinusNot described
Receives: Procedure: Z plasty and minimal excision of pilonidal sinus
Minimal excision of pilonidal sinusNot described
Receives: Procedure: Z plasty and minimal excision of pilonidal sinus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of recurrence

    Showing each of both procedures efficacy in decreasing rate of recurrence of PNS

    Measured: In about 6 month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Sep 2023
  2. Study start1 Dec 2023 (estimated)
  3. Primary completion1 Aug 2025 (estimated)
  4. Study completion1 Oct 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
2 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06021392
Sponsor's protocol ID
Techniques of PNS excision
Status last verified
Sep 2023
First submitted
28 Aug 2023
Last updated
7 Sep 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pilonidal Sinus, run by Abanoub emad fayez.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 7 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of recurrence (time frame: In about 6 month follow up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in